Fulgent Genetics (NASDAQ:FLGT – Get Free Report) updated its FY 2026 earnings guidance on Friday. The company provided earnings per share guidance of -1.450–1.450 for the period, compared to the consensus earnings per share estimate of -0.590. The company issued revenue guidance of $350.0 million-$350.0 million, compared to the consensus revenue estimate of $343.6 million. [...]
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2026 Earnings Guidance
